These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 14031703

  • 41. The myeloproliferative disorders. Current clinical and laboratory considerations.
    FRANCO JA.
    Calif Med; 1962 Dec; 97(6):352-4. PubMed ID: 14010293
    [Abstract] [Full Text] [Related]

  • 42. [The activity of the alkaline phosphatase of neutrophils in myeloproliferative diseases].
    Vakulenko AD, Shubich MG.
    Ter Arkh; 1966 Feb; 38(2):66-9. PubMed ID: 5235224
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Alkaline phosphatase activity of the neutrophils in essential polycythemia].
    Shcherbakova EG, Letskiĭ VB, Teodorovich VP.
    Probl Gematol Pereliv Krovi; 1971 Mar; 16(3):10-4. PubMed ID: 5119052
    [No Abstract] [Full Text] [Related]

  • 47. [Activity of lactic dehydrogenase in blood serum in polycythemia vera and osteomyelosclerosis (OMS)].
    Kwiatkowski S, Ojrzyński Z, Smolik R, Tawlas N.
    Pol Arch Med Wewn; 1967 Mar; 39(6):765-8. PubMed ID: 5583676
    [No Abstract] [Full Text] [Related]

  • 48. [Leukocyte sedimentation in myelofibrosis. Biological and clinical significance].
    Grignaffini GF, Tincani GP, Sgandurra A, Puviani G.
    Haematologica; 1966 Mar; 51(12):987-96. PubMed ID: 4967332
    [No Abstract] [Full Text] [Related]

  • 49. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J, Xue YP, Ye L, Yao JF, Zhou CL, Qian LS, Yang RC, Li HY, Zhang HY, Shao ZH.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
    [Abstract] [Full Text] [Related]

  • 50. [Myelofibrosis and leukemia (author's transl)].
    Gärtner U, Schief A, Rentsch I.
    Med Klin; 1973 Nov 09; 68(45):1475-9. PubMed ID: 4778418
    [No Abstract] [Full Text] [Related]

  • 51. [Frequency of the lowering of the rate of leukocyte alkaline phosphatases in the course of hematologic diseases].
    Najman A, Seger J, Bitoun A, Duhamel G, André R.
    Nouv Rev Fr Hematol; 1969 Nov 09; 9(2):302-6. PubMed ID: 4239792
    [No Abstract] [Full Text] [Related]

  • 52. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 53. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H, Spivak JL.
    Clin Adv Hematol Oncol; 2009 May 12; 7(5):334-42. PubMed ID: 19521323
    [Abstract] [Full Text] [Related]

  • 54. [Case of cryptogenic myelosclerosis with peripheral picture of Di Guglielmo's chronic erythremia].
    LENZI F, DI PERRI T.
    Haematologica; 1952 May 12; 36(9):953-70. PubMed ID: 13010623
    [No Abstract] [Full Text] [Related]

  • 55. Definition, clinical features and diagnosis of myelobibrosis.
    Takácsi-Nagy L, Gráf F.
    Clin Haematol; 1975 Jun 12; 4(2):291-308. PubMed ID: 1102189
    [No Abstract] [Full Text] [Related]

  • 56. [Significance of leukocyte alkaline phosphatase in Hodgkin's disease].
    Sforza MB, De Somoza N, Morgenfeld CM.
    Sangre (Barc); 1971 Jun 12; 16(4):411-6. PubMed ID: 5128061
    [No Abstract] [Full Text] [Related]

  • 57. Significance of leukocyte alkaline phosphatase in Hodgkin's disease.
    Bennett JM, Nathanson L, Rutenburg AM.
    Arch Intern Med; 1968 Apr 12; 121(4):338-41. PubMed ID: 5645706
    [No Abstract] [Full Text] [Related]

  • 58. Distinction between alkaline phosphatase and Mg2+-ATPase of the human polymorphonuclear leukocyte.
    Long G, DeChatelet LR, McCall CE, Bass DA, Cooper MR.
    Biochem Med; 1979 Aug 12; 22(1):88-97. PubMed ID: 159047
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.